Nuclein Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
77
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$15.7M
- Investors
-
9
Nuclein General Information
Description
Developer of a rapid PCR testing system designed to deliver lab results at the point of care. The company's system offers a DASH Rapid PCR (Polymerase Chain Reaction) system-of-care instrument with test cartridges that can run a wide variety of sample types, enabling healthcare providers to make treatment decisions with minimal hands-on time.
Contact Information
Website
www.nuclein.comCorporate Office
- 8305 Cross Park Drive
- Austin, TX 78754
- United States
Corporate Office
- 8305 Cross Park Drive
- Austin, TX 78754
- United States
Nuclein Timeline
Nuclein Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 27-Oct-2026 | $15.7M | Completed | Generating Revenue | ||
| 9. Later Stage VC | 04-Feb-2026 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 22-Mar-2023 | Completed | Generating Revenue | |||
| 7. Debt - General | 16-Nov-2023 | Cancelled | Generating Revenue | |||
| 6. Later Stage VC (Series B2) | 31-Aug-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 25-Mar-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 18-Feb-2020 | Cancelled | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Jan-2020 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 10-Sep-2019 | $420K | $420K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nuclein Comparisons
Industry
Financing
Details
Nuclein Competitors (3)
One of Nuclein’s 3 competitors is Biomeme, a Venture Capital-Backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biomeme | Venture Capital-Backed | Philadelphia, PA | ||||
| Visby Medical | Venture Capital-Backed | San Jose, CA | ||||
| ACON Laboratories | Corporate Backed or Acquired | San Diego, CA |
Nuclein Patents
Nuclein Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024073366-A2 | Methods of stabilizing a reducing agent | Inactive | 26-Sep-2022 | ||
| WO-2024073366-A3 | Methods of stabilizing a reducing agent | Inactive | 26-Sep-2022 | ||
| US-20240226887-A1 | Analyte detection cartridge and methods of use thereof | Pending | 27-Apr-2021 | ||
| US-20240002916-A1 | Direct lysis apparatus and methods for molecular diagnostics | Pending | 23-Nov-2020 | ||
| EP-4247934-A1 | Apparatus and methods for molecular diagnostics | Inactive | 17-Nov-2020 | B01L7/52 |
Nuclein Signals
Nuclein Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACC Bioscience Incubator | Accelerator/Incubator | |||
| Trinity Investors | Asset Manager | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Nuclein Acquisitions (1)
Nuclein’s most recent deal was a Merger/Acquisition with Minute Molecular. The deal was made on 12-May-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Minute Molecular | 12-May-2023 | Merger/Acquisition | Diagnostic Equipment |
Nuclein FAQs
-
When was Nuclein founded?
Nuclein was founded in 2017.
-
Where is Nuclein headquartered?
Nuclein is headquartered in Austin, TX.
-
What is the size of Nuclein?
Nuclein has 77 total employees.
-
What industry is Nuclein in?
Nuclein’s primary industry is Diagnostic Equipment.
-
Is Nuclein a private or public company?
Nuclein is a Private company.
-
What is Nuclein’s current revenue?
The current revenue for Nuclein is .
-
How much funding has Nuclein raised over time?
Nuclein has raised $68.9M.
-
Who are Nuclein’s investors?
ACC Bioscience Incubator, Trinity Investors, , , and are 5 of 9 investors who have invested in Nuclein.
-
Who are Nuclein’s competitors?
Biomeme, Visby Medical, and ACON Laboratories are competitors of Nuclein.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process